Search

Your search keyword '"Michael, Nelson L"' showing total 1,536 results

Search Constraints

Start Over You searched for: Author "Michael, Nelson L" Remove constraint Author: "Michael, Nelson L"
1,536 results on '"Michael, Nelson L"'

Search Results

301. Immune correlates of protection for dengue: State of the art and research agenda

302. Characteristics of HIV-infected U.S. Army soldiers linked in molecular transmission clusters, 2001-2012

303. Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection

304. CD4+ Cell infiltration into subcutaneous adipose tissue is not indicative of productively infected cells during acute SHIV infection

305. Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers

306. V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144

308. Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

309. Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women

310. Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant

311. Transcriptomic profiles of NK cell function indicate impaired responsiveness in chronic HIV-1 infection and enhanced functional activity post-vaccination

312. Understanding the determinants of CD8+ T cell immunodominance in acute HIV infection

313. Terminally differentiated CD8 effector T cells have NK-like features and are potent mediators of HIV-specific ADCC

314. Antibody responses induced to the C1 region of HIV-1 gp120 in acute HIV-1 infection and after vaccination

315. High Number of Activated CD8+ T Cells Targeting HIV Antigens Are Present in Cerebrospinal Fluid in Acute HIV Infection

316. Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens

317. The CD38+ HLA-DR+ PD-1+ CD4 T cell population represents a short-lived part of the viral reservoir and predicts poor immunologic recovery upon initiation of ART

318. A novel mechanism linking memory stem cells with innate immunity in protection against HIV-1 infection

319. HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania

320. Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial

322. A Recombinant Vesicular Stomatitis Virus Ebola Vaccine

323. An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria

324. Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques

325. Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

328. Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys

330. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor

331. New Subtype B Containing HIV-1 Circulating Recombinant of sub-Saharan Africa Origin in Nigerian Men Who Have Sex With Men.

332. Design and characterization of a self-assembling protein nanoparticle displaying HIV-1 Env V1V2 loop in a native-like trimeric conformation as vaccine antigen.

333. Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected Kenyans.

334. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.

335. Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

337. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection

338. Erratum: Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

339. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

342. Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG

344. Vaccine protection against Zika virus from Brazil

345. Initiation of Antiretroviral Therapy During Acute HIV-1 Infection Leads to a High Rate of Nonreactive HIV Serology

346. Sequential Dysfunction and Progressive Depletion of Candida albicans-Specific CD4 T Cell Response in HIV-1 Infection

347. Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand

348. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

349. Brief Report

350. Expansion of Inefficient HIV-Specific CD8 T Cells during Acute Infection

Catalog

Books, media, physical & digital resources